Pulsenmore Ltd. PLSM 深 沪
等待开盘 07-06 09:30:00 美东时间
4.54
-0.390
-7.91%
华盛通- 最 高5.22
- 今 开4.96
- 成交量 13.02万股
- 最 低 4.22
- 昨 收 4.93
- 总市值 2952.29万
- 52周最高 12.97
- 市盈率 静 --
- 换手率 2.00%
- 52周最低 3.0001
- 委 比 18.71%
- 总股本 650.28万
- 历史最高 12.97
- 量 比 0.27
- 振 幅 20.28%
- 历史最低 3.0001
- 每 手 1
- 风险率 1.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pulsenmore raises $7.5M in private placement; shares down
Pulsenmore (PLSM) entered into a private placement agreement with a healthcare-focused institutional investor. The company will sell 1.56M ordinary shares (or pre-funded warrants in lieu thereof) alon...
06-25 20:28
Why Is Pulsenmore Stock Soaring Wednesday?
Pulsenmore Ltd. (NASDAQ:PLSM) stock surged in Wednesday’s premarket trading after the home ultrasound company announced a partnership with Ouma Health to expand remote prenatal care services across the United States. The deal will integrate Pulsenmore’s FDA-authorized home ultrasound platform into O...
06-24 21:12
Pulsenmore FY EPS $(0.77), Sales $12.547M
Pulsenmore (NASDAQ:PLSM) reported quarterly losses of $(0.77) per share. The company reported $12.547 million in sales this quarter.
03-30 21:32
Pulsenmore Ltd. reports FY results
Pulsenmore Ltd. press release (PLSM): FY revenue of $12.5M (+380.8% Y/Y). Net loss was $5M for the year ended December 31, 2025, compared to $10M for the year ended December 31, 2024. More on Pulsenm...
03-30 21:29
Pulsenmore publishes investor presentation on FDA-cleared home-use maternal ultrasound platform
Pulsenmore publishes investor presentation on FDA-cleared home-use maternal ultrasound platform Pulsenmore highlighted FDA De Novo clearance for its home-use maternal ultrasound system in Nov. 2025, positioning it for U.S. market entry tied to 3.6 million annual deliveries. Platform metrics showed m
03-30 20:49
Pulsenmore FY 2025 Sales $12.547M, Up 374% YoY, Net Loss Of $5M Vs. $10M YoY
Full-Year 2025 Financial HighlightsFull year revenue of $12.5 million, representing a 374% increase compared to 2024, including a one-time revenue contribution of $9.6 million related to the GE settlement discussed
03-30 20:36
Pulsenmore FY25 net loss narrows 50% to USD 5 million; revenue jumps to USD 12.5 million
Pulsenmore FY25 net loss narrows 50% to USD 5 million; revenue jumps to USD 12.5 million Pulsenmore posted a net loss of USD 5 million, narrowing 50% from the prior year. Revenue climbed to USD 13 million, up 374% on a one-time USD 9.6 million contribution tied to a settlement with GE Precision Heal
03-30 20:30
Earnings Scheduled For March 30, 2026
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
Pulsenmore Announces Full Year 2025 Earnings Conference Call
OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results ...
03-25 20:00
Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical ...
02-02 20:13
